[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Page 28518]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-11364]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Mycoplasma genitalium Among
Women Attending Family Planning and STD Clinics in the US: Assessing
Burden, Risk Factors, Sequelae, Antibiotic Resistance, and Association
with Treatment Outcomes, Special Interest Project (SIP)14-033; and
Prospective Study of Immune Response to Chlamydial Infection to Inform
Development of Rational Prevention Strategies, SIP14-034, Panel I,
initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 2:00 p.m.-6:00 p.m., June 4, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Mycoplasma genitalium Among Women Attending Family
Planning and STD Clinics in the US; Assessing Burden, Risk Factors,
Sequelae, Antibiotic Resistance, and Association with Treatment
Outcomes, SIP14-033; and Prospective Study of Immune Response to
Chlamydial Infection to Inform Development of Rational Prevention
Strategies, SIP14-034, Panel I, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-11364 Filed 5-15-14; 8:45 am]
BILLING CODE 4163-18-P